Emerging role of nanocarriers to increase the solubility and bioavailability of curcumin

被引：177

作者：

Mohanty, Chandana ^{[1
]}

Das, Manasi ^{[1
]}

Sahoo, Sanjeeb K. ^{[1
]}

机构：

[1] Inst Life Sci, Lab Nanomed, Bhubaneswar 751023, Orissa, India

来源：

EXPERT OPINION ON DRUG DELIVERY | 2012年 / 9卷 / 11期

关键词：

absorption; bioavailability; curcumin; metabolism; nanocarrirer; poor solubility; SEE VOL. 9; LOADED LIPID NANOPARTICLES; IN-VITRO; PLGA NANOPARTICLES; ANTIINFLAMMATORY AGENT; BIOLOGICAL-ACTIVITIES; ORAL BIOAVAILABILITY; COPOLYMERIC MICELLES; CONTROLLED DELIVERY; CELL-PROLIFERATION;

D O I：

10.1517/17425247.2012.724676

中图分类号：

R9 [药学];

学科分类号：

100702 [药剂学];

摘要：

Introduction: Curcumin is a safe, affordable and natural bioactive molecule of turmeric (Curcuma longa). It has gained considerable attention in recent years for its multiple pharmacological activities. However, its optimum pharmaceutical potential has been limited by its lack of aqueous solubility and poor bioavailability. To mitigate the above limitations, recently various nanostructured water-soluble delivery systems were developed to increase the solubility and bioavailability of curcumin. Areas covered: Major reasons contributing to the low bioavailability of curcumin appear to be owing to its poor solubility, low absorption, rapid metabolism and rapid systemic elimination. The present review summarizes the strategies using curcumin in various nanocarrier delivery systems to overcome poor solubility and inconsistent bioavailability of curcumin and describes the current status and challenges for the future. Expert opinion: The development of various drug delivery systems to deliver curcumin will certainly provide a step up towards augmenting the therapeutic activity of curcumin thereby increasing the solubility and bioavailability of curcumin. However, the future of such delivery technology will be highly dependent on the development of safe, non-toxic and non-immunogenic nanocarriers.

引用

页码：1347 / 1364

页数：18

共 132 条

[1]

Dendrimers Bind Antioxidant Polyphenols and cisPlatin Drug [J].

Abderrezak, Amine ;

Bourassa, Philippe ;

Mandeville, Jean-Sebastian ;

Sedaghat-Herati, Reza ;

Tajmir-Riahi, Heidar-Ali .

PLOS ONE, 2012, 7 (03)

[2]

Sustained targeting of Bcr-Abl plus leukemia cells by synergistic action of dual drug loaded nanoparticles and its implication for leukemia therapy [J].

Acharya, Sarbari ;

Sahoo, Sanjeeb K. .

BIOMATERIALS, 2011, 32 (24) :5643-5662

[3]

Cyclodextrin-mediated entrapment of curcuminoid 4-[3,5-bis(2-chlorobenzylidene-4-oxo-piperidine-1-yl)-4-oxo-2-butenoic acid] or CLEFMA in liposomes for treatment of xenograft lung tumor in rats [J].

Agashe, Hrushikesh ;

Sahoo, Kaustuv ;

Lagisetty, Pallavi ;

Awasthi, Vibhudutta .

COLLOIDS AND SURFACES B-BIOINTERFACES, 2011, 84 (02) :329-337

[4]

Aggarwal BB, 2003, ANTICANCER RES, V23, P363

[5]

Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets [J].

Aggarwal, Bharat B. ;

Sung, Bokyung .

TRENDS IN PHARMACOLOGICAL SCIENCES, 2009, 30 (02) :85-94

[6]

Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases [J].

Aggarwal, Bharat B. ;

Harikumar, Kuzhuvelil B. .

INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2009, 41 (01) :40-59

[7]

Curcumin (diferuloylmethane) down-regulates expression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IκBα kinase and Akt activation [J].

Aggarwal, S ;

Ichikawa, H ;

Takada, Y ;

Sandur, SK ;

Shishodia, S ;

Aggarwal, BB .

MOLECULAR PHARMACOLOGY, 2006, 69 (01) :195-206

[8]

PAC, a novel curcumin analogue, has anti-breast cancer properties with higher efficiency on ER-negative cells [J].

Al-Hujaily, Ensaf M. ;

Mohamed, Ameera Gaafar ;

Al-Sharif, Ibtehaj ;

Youssef, Khairia M. ;

Manogaran, Pulicat S. ;

Al-Otaibi, Basem ;

Al-Haza'a, Amal ;

Al-Jammaz, Ibrahim ;

Al-Hussein, Khaled ;

Aboussekhra, Abdelilah .

BREAST CANCER RESEARCH AND TREATMENT, 2011, 128 (01) :97-107

[9]

Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature [J].

Anand, Preetha ;

Thomas, Sherin G. ;

Kunnumakkara, Ajaikumar B. ;

Sundaram, Chitra ;

Harikumar, Kuzhuvelil B. ;

Sung, Bokyung ;

Tharakan, Sheeja T. ;

Misra, Krishna ;

Priyadarsini, Indira K. ;

Rajasekharan, Kallikat N. ;

Aggarwal, Bharat B. .

BIOCHEMICAL PHARMACOLOGY, 2008, 76 (11) :1590-1611

[10]

Bioavailability of curcumin: Problems and promises [J].

Anand, Preetha ;

Kunnumakkara, Ajaikumar B. ;

Newman, Robert A. ;

Aggarwal, Bharat B. .

MOLECULAR PHARMACEUTICS, 2007, 4 (06) :807-818

← 1 2 3 4 5 6 7 8 9 10 →